5. Inclusion Criteria
In order to ensure the most complete and accurate data is available for national comparative reporting, the Clinical Trials QPI Formal Review Group have agreed specific inclusion criteria for the measurement of this QPI:
- The clinical trials access QPI will be measured for patients with a confirmed cancer diagnosis that aligns to those tumour types with nationally agreed QPIs.
- Clinical trials must be approved by the National Institute for Health Research ( NIHR) or the Chief Scientist Office ( CSO) as eligible for addition to the UKCRN portfolio. This will incorporate interventional trials, translational research and observational studies. The definition of eligibility for addition to the UKCRN Portfolio  is detailed in appendix 4.
Updated sections 1-4 in line with all formal review QPI documents.
Removed the section on Clinical Trials Definitions.
Added section 5: Inclusion Criteria
Added appendix 4: CSO eligibility for addition to the UKCRN Portfolio
Email: Chris Booth, email@example.com
Phone: 0300 244 4000 – Central Enquiry Unit
The Scottish Government
St Andrew's House